Relationship between metabolic disorders and relative risk values of brain infarction estimated by protein-conjugated acrolein, IL-6 and CRP together with age

Clinica Chimica Acta

Volumn 412, Issue 3-4, 2011, Pages 339-342

  Yoshida, Madoka ^a   Mizoi, Mutsumi ^a   Saiki, Ryotaro ^a   Kobayashi, Eiichi ^a   Saeki, Naokatsu ^a   Wakui, Kenji ^b   Kusaka, Tadafumi ^c   Takizawa, Hirotaka ^d   Kashiwado, Koichi ^d   Suzuki, Norikazu ^e   Fukuda, Kazumasa ^f   Nakamura, Takao ^f   Watanabe, Sakae ^g   Tada, Kei ^g   Tomitori, Hideyuki ^h   Kashiwagi, Keiko ^h   Igarashi, Kazuei ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Chiba Neurosurgical Clinic   (Japan)

^c Kusaka Clinic   (Japan)

^d Portsquare Kashiwado Clinic   (Japan)

^e Suzuki Neurosurgical Clinic   (Japan)

^f Chiba Central Medical Center   (Japan)

^g Saisei Hospital   (Japan)

^h CHIBA INSTITUTE OF SCIENCE   (Japan)

Author keywords

CRP; Hypertension; IL 6; Metabolic disorder; Protein conjugated acrolein; Silent brain infarction

Indexed keywords

ACROLEIN; C REACTIVE PROTEIN; INTERLEUKIN 6; PROTEIN CONJUGATED ACROLEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SILENT BRAIN INFARCTION; WHITE MATTER;

ACROLEIN; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN INFARCTION; C-REACTIVE PROTEIN; CAROTID ARTERIES; FEMALE; HUMANS; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC DISEASES; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 78650248875     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.11.003     Document Type: Article

References (21)

1. Igarashi K., Kashiwagi K. Modulation of cellular function by polyamines. Int J Biochem Cell Biol 2010, 42:39-51.
2. Watanabe S., Kusama-Eguchi K., Kobayashi H., Igarashi K. Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem 1991, 266:20803-20809.
3. Tomitori H., Usui T., Saeki N., et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005, 36:2609-2613.
4. Saiki R., Nishimura K., Ishii I., et al. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 2009, 40:3356-3361.
5. Igarashi K., Ueda S., Yoshida K., Kashiwagi K. Polyamines in renal failure. Amino Acids 2006, 31:477-483.
6. Higashi K., Yoshida M., Igarashi A., et al. Intense correlation between protein-conjugated acrolein and primary Sjögren's syndrome. Clin Chim Acta 2010, 411:359-363.
7. Kobayashi S., Okada K., Koide H., Bokura H., Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997, 28:1932-1939.
8. Vermeer S.E., Hollander M., van Dijk E.J., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 2003, 34:1126-1129.
9. Lopez O.L., Jagust W.J., Dulberg C., et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: Part 2. Arch Neurol 2003, 60:1394-1399.
10. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New Engl J Med 1999, 340:14-22.
11. Inoue K., Matsumoto M., Shono T., Toyokawa S., Moriki A. Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts. J Stroke Cerebrovasc Dis 2007, 16:14-20.
12. Bokura H., Kobayashi S., Yamaguchi S., et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: A prospective cohort study. J Stroke Cerebrovasc Dis 2006, 15:57-63.
13. Yoshida M., Higashi K., Kobayashi E., et al. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis 2010, 211:475-479.
14. Ninomiya J.K., L'Italien G., Criqui M.H., et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 2004, 109:42-46.
15. Kwon H.M., Kim B.J., Lee S.H., et al. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 2006, 37:466-470.
16. Yoshida M., Tomitori H., Machi Y., et al. Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis 2009, 203:557-562.
17. Hoshi T., Kitagawa K., Yamagami H., et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005, 36:768-772.
18. Shinohara Y., Tohgi H., Hirai S., et al. Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study) 1: Design and results at enrollment. Cerebrovasc Dis 2007, 24:202-209.
19. Makita S., Nakamura M., Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005, 36:2138-2142.
20. Yamagami H., Kitagawa K., Hoshi T., et al. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005, 25:1458-1462.
21. Ellenius J., Groth T., Lindahl B., Wallentin L. Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis. Clin Chem 1997, 43:1919-1925.